Breaking News Headlines Today | Ground News

See every side of every news story

Adaptimmune Therapeutics Plc image

News from Adaptimmune Therapeutics plc

Adaptimmune Therapeutics Plc’s media bias is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

Adaptimmune Therapeutics Plc’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Adaptimmune Therapeutics Plc

Where is Adaptimmune Therapeutics Plc located?Adaptimmune Therapeutics Plc's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Adaptimmune Therapeutics Plc News

Adaptimmune Announces Delisting from Nasdaq

Oxford, Pennsylvania · Oxford

Adaptimmune Announces Delisting from Nasdaq

Philadelphia, Pennsylvania and Oxford, United Kingdom--(Newsfile Corp. - October 20, 2025) - Adaptimmune Therapeutics plc (NASDAQ: ADAP)See the Story